AnaptysBio Inc buy Guggenheim
Start price
10.03.25
/
50%
€15.30
Target price
10.03.26
-
Performance (%)
166.67%
Price
18.12.25
€40.80
Summary
This prediction is currently active. With a performance of 166.67% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 10.03.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 7.368% | 7.368% |
| iShares Core DAX® | 0.299% | 4.394% |
| iShares Nasdaq 100 | 0.666% | 1.175% |
| iShares Nikkei 225® | -0.656% | -0.055% |
| iShares S&P 500 | 0.352% | 1.378% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for ANAB provided by MarketBeat